Literature DB >> 7226489

Cholesterol, lipoproteins, apoproteins, and heart disease: present status and future prospects.

R I Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7226489

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  11 in total

1.  The liver metabolite S-422 of the hypolipidaemic drug benfluorex decreases cholesterol esterification in fibroblasts and monocyte-like cells.

Authors:  J C Mazière; C Mazière; M Auclair; L Mora; O Arnaud
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Interrelationship between serum lipid profile, serum hormones and other components of the metabolic syndrome.

Authors:  M Garaulet; F Pérez-Llamas; S Zamora; F J Tebar
Journal:  J Physiol Biochem       Date:  2002-09       Impact factor: 4.158

3.  5 alpha-Cholest-8(14)-en-3 beta-ol-15-one, a potent inhibitor of sterol biosynthesis, lowers serum cholesterol and alters distributions of cholesterol in lipoproteins in baboons.

Authors:  G J Schroepfer; E J Parish; A Kisic; E M Jackson; C M Farley; G E Mott
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

4.  The effect of dietary lipid on the lipoprotein status of the Mongolian gerbil.

Authors:  A B Leach; B J Holub
Journal:  Lipids       Date:  1984-01       Impact factor: 1.880

5.  5 alpha-Cholest-8(14)-en-3 beta-ol-15-one lowers serum cholesterol and induces profound changes in the levels of lipoprotein cholesterol and apoproteins in monkeys fed a diet of moderate cholesterol content.

Authors:  G J Schroepfer; B C Sherrill; K S Wang; W K Wilson; A Kisic; T B Clarkson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  Smooth muscle and endothelial cell function in the pathogenesis of atherosclerosis.

Authors:  A I Gotlieb
Journal:  Can Med Assoc J       Date:  1982-04-15       Impact factor: 8.262

7.  [Concentrations of the main lipoprotein density classes in disturbances of thyroid function in man (author's transl)].

Authors:  H J Lisch; M Ogriseg; C Breier; H Drexel; H Fill; S Sailer
Journal:  Klin Wochenschr       Date:  1982-04-01

8.  Lack of correlation between serum lipoproteins and biliary cholesterol saturation in patients with gallstones.

Authors:  J W Marks; P A Cleary; J J Albers
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

Review 9.  The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism.

Authors:  Elaine Regina Delicato de Almeida; Edna Maria Vissoci Reiche; Ana Paula Kallaur; Tamires Flauzino; Maria Angelica Ehara Watanabe
Journal:  Biomed Res Int       Date:  2013-11-12       Impact factor: 3.411

10.  Tamoxifen, serum lipoproteins and cardiovascular risk.

Authors:  P F Bruning; J M Bonfrer; A A Hart; M de Jong-Bakker; D Linders; J van Loon; W J Nooyen
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.